MAIA

MAIA Biotechnology (MAIA)

About MAIA Biotechnology (MAIA)

MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded on August 3, 2018 and is headquartered in Chicago, IL.

Details

Daily high

$1.35

Daily low

$1.22

Price at open

52 Week High

$2.74

52 Week Low

$0.87

Market cap

45.5M

Dividend yield

0.00%

Volume

Avg. volume

961,783

P/E ratio

-1.65

MAIA Biotechnology News